-
Call Me Crazy: 2 New Short Positions
Wednesday, September 1, 2010 - 2:51pm | 244One very bullish day isn't going to waver my belief and alter what I know the chart are showing, and that is more downside in this market. With that being the case, I used today as an opportunity to reload on some additional short positions. I was able, despite getting stopped out of DDS, to re-up...
-
Allscripts and Eclipsys Merge (MDRX
Wednesday, September 1, 2010 - 7:13am | 51Allscripts (Nasdaq: MDRX) today will announce the completion of the merger of Allscripts-Misys Healthcare Solutions, Inc. with Eclipsys Corporation. Allscripts is one of the largest companies focused exclusively on healthcare information technology, with over 5,500 employees and combined 2009 pro...
-
NASDAQ Stocks Hitting 52-Week Highs (RDCM, ARMH, AMRN, SXCI)
Tuesday, August 31, 2010 - 12:49pm | 178Radcom Ltd (NASDAQ: RDCM) shares climbed 3.49% to create a new 52-week high of $8.90. RDCM’s shares have advanced 1,016.88% over the past 52 weeks, while the S&P 500 index has just gained 2.77% in the same period. ARM Holdings Plc (NASDAQ: ARMH) shares rose 7.11% to touch a new 52-week high of...
-
Kendall Law Group Investigates A.D.A.M. Inc. Acquisition (ADAM)
Monday, August 30, 2010 - 3:01pm | 72Kendall Law Group is investigating A.D.A.M. Inc. (Nasdaq: ADAM) for shareholders in connection with the proposed acquisition by Ebix Inc. The firm is investigating whether A.D.A.M. properly shopped the Company prior to entering into the agreement. This possible breach of fiduciary duty may have...
-
NASDAQ Stocks Hitting 52-Week Highs (FOSL, ADAM, QLIK, HOOK)
Monday, August 30, 2010 - 11:38am | 185Fossil Inc (NASDAQ: FOSL) shares reached $48.39 to create a new 52-week high, before falling to $48.19, representing a 4.73% gain. The board of FOSL has approved a $750 million stock repurchase plan. ADAM Inc (NASDAQ: ADAM) shares jumped 76.66% to touch a new 52-week high of $5.60. Ebix Inc (NASDAQ...
-
ADAM Advances On Merger News
Monday, August 30, 2010 - 9:48am | 90Shares of ADAM Inc (NASDAQ: ADAM) surged after it entered into a merger agreement with Ebix Inc (NASDAQ: EBIX). ADAM’s shares jumped 75.39% to $5.56 at 10:41 am. EBIX has entered into an agreement to acquire ADAM on a debt-free basis for a consideration of $66 million. ADAM’s shares have lost 0.94...
-
Mid-Day Market Movers (ADAM, MPB, COGT, XFN)
Monday, August 30, 2010 - 9:42am | 173ADAM Inc (NASDAQ: ADAM) jumped 77.60% to $5.63 at 10:23 am. Ebix Inc (NASDAQ: EBIX) has entered into a merger agreement to acquire ADAM on a debt-free basis for $66 million. Mid Penn Bancorp (NASDAQ: MPB) climbed 29.51% to $7.97. MPB’s shares have lost 61.56% over the past 52 weeks, while the S...
-
Benzinga’s Top Upgrades (ARI, CAVM, NBL, CERN)
Monday, August 30, 2010 - 8:02am | 158Apollo Commercial Real Est. Finance Inc (NYSE: ARI) was upgraded by FBR Capital to "outperform." ARI’s’ shares closed at $16.89 on Friday. ARI’s earnings are likely to increase by 29.85% in the next year. JMP Securities upgraded Cavium Networks Inc (NASDAQ: CAVM) from "market perform" to "...
-
Morgan Keegan Has Outperform Rating On Allscripts Healthcare Solutions (MDRX)
Thursday, August 26, 2010 - 7:21am | 280Morgan Keegan has an Overweight rating and $24 price target on shares of Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX), as the company just closed its merger with Eclipsys. In the research report for investors, Morgan Keegan writes, "We have combined our Allscripts and Eclipsys models, and...
-
Oppenheimer Takes A Look At Heathcare IT Spending (MDRX)
Thursday, August 26, 2010 - 6:54am | 274Oppenheimer surveyed CFO's in the hospital industry with regards to its information technology spending. In the report it highlights Allscripts-Misys Healthcare Solutions (NASDAQ: MDRX). In a note to clients, Oppenheimer writes, "...The results of our CFO survey are largely consistent with our...
-
Medical Devices Industry Outlook - August 2010 - Industry Outlook
Tuesday, August 24, 2010 - 6:15pm | 2101Prelude The global medical devices industry is fairly large, intensely competitive and highly innovative with annual worldwide sales in 2009 in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology,...
-
Oppenheimer Raising Target On Allscripts-Misys Healthcare Solutions (MDRX)
Tuesday, August 24, 2010 - 9:13am | 173Oppenheimer & Co. is raising its price target and earnings estimates on shares of Allscripts-Misys Healthcare Solutions, Inc. (NASDAQ: MDRX) after a secondary offering last week. It has a $22 price target, up from $20. In the research, Oppenheimer writes, "We officially raise our estimates for...
-
Merge Upgraded to Neutral - Analyst Blog
Monday, August 23, 2010 - 7:22am | 466We have upgraded Merge Healthcare (MRGE) to Neutral with a target price of $2.75. Merge reported adjusted net loss per share of 3 cents compared with the Zacks Consensus Estimate of loss per share of 2 cents. Revenues were $29 million, up 89% from the year-ago quarter. This is not comparable since...
-
Athenahealth Offers Stand-alone HER - Analyst Blog
Monday, August 23, 2010 - 7:21am | 628Leading medical billing and records software provider Athenahealth Inc (ATHN) has announced that from now on it will offer its web-based "athenaClinicals" electronic health record (EHR) service on a stand-alone basis to hospitals and community physicians. Previously, the customers were required...
-
Allscripts Completes Secondary Offering and $577.4 M Repurchase (MDRX)
Friday, August 20, 2010 - 11:15am | 130Allscripts-Misys Healthcare Solutions, Inc. (NASDAQ: MDRX) today announced that certain wholly-owned subsidiaries of Misys plc, Allscripts' majority stockholder, have completed their previously announced underwritten public offering of 27,000,000 shares of Allscripts common stock at a public...